Companies/UK/4BB

4BASEBIO PLC

Last · LSE£5.42-0.205 (-3.64%)live · yahoo · 1h ago
Vol 237 ≈ 128.5K
Market cap£83.9M15.5M sh
P/E · TTM-467fwd -6.4 · eps -1.16 · loss
Beta0.81vs S&P 500
Div yield0.00%annual · TTM
52w range
£4.20£8.20
Volume237session

Issuer

Legal name4BASEBIO PLC
HQUnited Kingdom (UK)
ListingLN 4BB
ISINGB00BMCLYF79
LEI213800E2DX9EAIUNCB30
SectorHealthcare
IndustryBiotechnology & Medical Research
CurrencyGBP
Entity registryisin:GB00BMCLYF79
Website4basebio.com
LinkedIn
Employees140
Address4basebio Plc 25 Norman Way CB24 5QE, Cambridge +44 1223 967 943
Loading chart…

Press & signals

1 recent
  • GlobeNewswire

    4basebio and Genezen Enter into Strategic Collaboration to Advance Synthetic, Cell-Free DNA Platforms for Next-Generation Viral Vector Manufacturing

Documents

FormReporting forFiledFlags
interim reportInterim report 2026IR
—2026-09-290
otherAnnual+Report+2025IR
—2026-09-290
slides4basebio RBC+Investor+Event+PresentationIR
—2026-09-290
annual reportIR
—2025-12-31≈0
interim reportHalf Year Report 30 June 2025IR
—2025-09-290
Showing 5 of 26 filings